iifl-logo

Syngene International Ltd Historical Data

673.95
(-3.42%)
Aug 6, 2025|11:44:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Syngene International Ltd Historical Data

06/07/2025calendar-icon
06/08/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

07-Jul-2025

639

646632.8635.2518,49236,36,76,580.93,68,093

08-Jul-2025

635.25

637.55627.35632.631,03848,47,07,4044,79,856

09-Jul-2025

636.55

642.95633.85639.234,91272,02,32,214.558,49,720

10-Jul-2025

640

641630.3634.321,00729,45,79,541.52,29,437

11-Jul-2025

633

635.25621.35626.1528,69667,00,96,386.557,09,006

14-Jul-2025

625

645.65620.7636.334,78894,51,07,013.4511,19,032

15-Jul-2025

642.3

659.9642.2655.3538,9671,28,96,25,64110,72,628

16-Jul-2025

659.75

671.9655.35667.7544,54792,18,82,721.95,30,081

17-Jul-2025

672.2

678668670.443,63577,78,80,445.26,16,005

18-Jul-2025

671.05

672.1656.05657.2518,14559,72,90,678.556,27,889

21-Jul-2025

658.05

673653.6671.0533,08265,21,45,109.74,53,570

22-Jul-2025

674

686.5661.9567655,3181,12,33,85,539.556,24,952

23-Jul-2025

674

690664.45680.7598,9492,85,45,41,781.422,18,582

24-Jul-2025

677.85

684.55660.8669.7550,6161,41,73,82,806.1510,93,502

25-Jul-2025

667.4

693665.7681.164,7792,06,64,37,759.3512,85,003

28-Jul-2025

681.1

699.5678.15690.539,32387,65,51,906.454,15,510

29-Jul-2025

692

712.75687.4711.440,5971,31,51,73,427.259,66,705

30-Jul-2025

711.85

728.6710722.051,00,9351,83,12,42,235.113,02,718

31-Jul-2025

704.15

718701.5571425,73961,05,59,628.13,33,872

01-Aug-2025

714

714.35700.15703.2526,66864,68,32,622.255,49,245

04-Aug-2025

700

707.8691704.7518,80478,17,19,957.558,27,570

05-Aug-2025

704.75

709.5695697.823,73061,01,93,1145,22,568

Syngene Intl.: Related NEWS

Syngene Gets FDA Nod on Biocon Park Inspection With VAI Status
15 Jun 2025|09:00 PM

The outcome of the inspection has been classified as “Voluntary Action Indicated” or VAI.

Read More
Syngene Reports ₹1,018 Crore Revenue in Q4 FY25
24 Apr 2025|01:21 PM

The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.

Read More
Syngene International reports better than expected Q4 results
24 Apr 2025|11:36 AM

The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.

Read More
Syngene Boosts Biologics Capacity with US Facility Acquisition
13 Mar 2025|01:40 PM

This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.

Read More
Syngene Reports 18% Profit Surge in Q3, Revenue Up 10.6%
24 Jan 2025|12:45 PM

The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.